Company Filing History:
1 out of 260 
1 out of 16 Years Active: 2022
Title: The Innovative Contributions of Inventor Yang Mi Lim
Introduction
Yang Mi Lim is a notable inventor based in Yongin-si, South Korea. With a focus on advancements in cancer treatment, he has made significant contributions to the field of biotechnology. Through his innovative work, he aims to enhance the effectiveness of cancer therapies.
Latest Patents
Yang Mi Lim holds a patent for an "Anti-MSLN antibody and pharmaceutical composition for cancer treatment." This groundbreaking invention relates to an anti-MSLN antibody that exhibits high affinity and specificity for MSLN, making it a promising candidate for the prevention and treatment of various cancers. The pharmaceutical composition comprising this antibody represents a significant step forward in cancer therapy.
Career Highlights
Throughout his career, Yang Mi Lim has worked with esteemed organizations, including the Green Cross Corporation and the Mogam Institute for Biomedical Research. His experiences in these institutions have contributed to his expertise and productivity as an inventor.
Collaborations
In his journey of innovation, Yang Mi Lim has collaborated with prominent colleagues such as Ki Su Kim and Jung Hong Jeong. Their combined efforts have bolstered research initiatives and fostered advancements in cancer treatment technologies.
Conclusion
Yang Mi Lim exemplifies the spirit of innovation within the scientific community. Through his focused work on anti-MSLN antibodies and the development of effective cancer treatments, he continues to inspire future inventors and researchers in the field. His contributions remind us of the importance of persistence and collaboration in the pursuit of groundbreaking advancements.